Note 9. Stockholders’ Equity

 

Common Stock

 

The total number of shares of common stock, $0.001 par value, that the Company is authorized to issue is 250,000,000.

Issuer Purchases of Equity Securities

 

 On December 21, 2018, the Board authorized a share repurchase program under which the Company was authorized to repurchase up to $3.5 million of the Company’s outstanding shares of common stock, or approximately 312,497 common shares, in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Securities Exchange Act. The December 21, 2018 share repurchase program expired on May 31, 2019 and was renewed on September 5, 2019 and March 26, 2020. Under the March 26, 2020 share repurchase program, the Board authorized the repurchase of up to $2.0 million worth of common shares.

As of December 31, 2020, the Company repurchased an aggregate 384,368 shares of its outstanding common stock, including three privately negotiated purchases outside of the share repurchase programs, at a total cost of $4.2 million or $11.06 per share. The program expired on September 30, 2020. 

Preferred Stock

The Company’s board of directors (the “Board”) may, without further action by the stockholders, issue one or more series of preferred stock and fix the rights and preferences of those shares, including the dividend rights, dividend rates, conversion rights, exchange rights, voting rights, terms of redemption, redemption price or prices, liquidation preferences, the number of shares constituting any series and the designation of such series. As of December 31, 2020, no shares of preferred stock have been issued.

Stock Compensation Plans

The Company’s 2010 Stock Incentive Plan (the “2010 Stock Incentive Plan”) provides for options, restricted stock, and other customary forms of equity to be granted to the Company’s directors, officers, employees, and independent contractors. All forms of equity incentive compensation are granted at the discretion of the Board and have a term not greater than 10 years from the date of grant.

The calculation of the fair values of our stock-based compensation plans requires estimates that require management’s judgments. Under ASC 718, the fair value of each stock option is estimated on the grant date using the Black-Scholes option-pricing model. The valuation models require assumptions and estimates to determine expected volatility, expected life and expected risk-free interest rates. The expected volatility was determined using historical volatility of our stock based on the contractual life of the award. The risk-free interest rate assumption was based on the yield on zero-coupon U.S. Treasury strips at the award grant date. In valuing options granted in the fiscal years ended December 31, 2020 and 2019, we used the following weighted average assumptions: 

   

For the Year Ended

December 31,

 
    2020     2019  
Risk-free interest rate     0.40 - 0.47%       2.2%  
Expected stock-price volatility     47.9 - 48.3%        31.8%  
Expected life      6.2 years        5.8 years  

 

The following table summarizes activities under the 2010 Stock Incentive Plan for the indicated periods:

 

    Options Outstanding        
    Number of
Shares
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term
(in years)
    Aggregate
Intrinsic
Value (in
thousands)
 
Balances, December 31, 2018     190,000     $ 11.25       4.9     $ 90.0  
Options canceled and retired                            
Options exercised                            
Options granted     112,500       12.50                  
Balances, December 31, 2019     302,500       11.71       5.9       313.4  
Options canceled and retired                            
Options exercised                            
Options granted     60,000       16.29                  
Balances, December 31, 2020     362,500       12.47       5.6       810.1  
                                 
Options vested and exercisable and expected to be vested and exercisable at December 31, 2020     362,500     $ 12.47       5.6     $ 810.1  
Options vested and exercisable at December 31, 2020     158,750     $ 12.11       5.6     $ 362.1  

 

At December 31, 2020, there were 1.2 million shares reserved for issuance under the 2010 Stock Incentive Plan, and the Company had $0.4 million of total unrecognized stock option expense, net of estimated forfeitures, which will be recognized over the weighted average remaining period of 1.3 years.

 

The following table summarizes significant ranges of outstanding and exercisable options as of December 31, 2020:

Exercise
Prices
    Number
Outstanding
    Weighted  
Average
Remaining  
Contractual
Life (in Years)
    Weighted  
Average
Exercise
Price Per
Share
    Number
Exercisable
    Weighted
Average
Exercise
Price Per
 Share
 
  8.30       75,000       1.4     $ 8.30       18,750     $ 8.30  
  9.61       15,000       5.5       9.61       15,000       9.61  
  12.50       75,000       8.1       12.50       50,000       12.50  
  12.50       37,500       8.4       12.50       25,000       12.50  
  13.70       100,000       3.6       13.70       50,000       13.70  
  16.29       15,000       9.4       16.29             16.29  
  16.29       15,000       9.5       16.29             16.29  
  16.29       30,000       9.3       16.29             16.29  
  Total       362,500       5.6     $ 12.47       158,750     $ 12.11  

 

Employee stock-based compensation expense recognized for time-vesting options for the years ended December 31, 2020 and 2019, uses the Black-Scholes option pricing model for estimating the fair value of options granted under the Company’s equity incentive plans. Risk-free interest rates for the options were taken from the Daily Federal Yield Curve Rates on the grant dates for the expected life of the options as published by the Federal Reserve. The expected volatility was based upon historical data and other relevant factors such as the Company’s changes in historical volatility and its capital structure, in addition to mean reversion. Employee stock-based compensation expense recognized for market performance-vesting options uses a binomial lattice model for estimating the fair value of options granted under the Company’s equity incentive plan.

 

In calculating the expected life of stock options, the Company determines the amount of time from grant date to exercise date for exercised options and adjusts this number for the expected time to exercise for unexercised options. The expected time to exercise for unexercised options is calculated from grant as the midpoint between the expiration date of the option and the later of the measurement date or the vesting date. In developing the expected life assumption, all amounts of time are weighted by the number of underlying options.

 

During the year ended December 31, 2020, 8,305 restricted shares were granted and 37,989 restricted shares vested. During the year ended December 31, 2019, 57,155 restricted shares were granted and 12,500 restricted shares vested. As of December 31, 2020 and 2019, there were 27,471 and 44,655 shares of restricted stock outstanding.

 

In October 2019, the Board approved a change in the compensation plan for non-employee directors such that each non-employee director shall receive an annual cash retainer of $45,000 payable quarterly in arrears and an annual equity retainer of $25,000 payable in advance annually on October 1 of restricted shares of the Company’s common stock, subject to a one year cliff vesting period. In addition, each member of (i) the Audit Committee shall receive an additional fee of $11,000 payable quarterly in arrears; (ii) the Compensation Committee shall receive an additional fee of $2,000 payable quarterly in arrears and (iii) the Governance Committee shall receive an additional fee of $4,000 payable quarterly in arrears. Each non-employee director has the option to elect to receive up to 100 percent of the annual cash retainer in shares of the Company’s common stock.

 

During the years ended December 31, 2020 and 2019, the Board approved compensation for Board services by granting 24,940 and 25,574 shares, respectively, of common stock as compensation for the non-employee directors. The Company recorded $0.3 million and $0.2 million in Board compensation expense during the years ended December 31, 2020 and 2019, respectively. The Company recorded aggregate stock-based compensation expense, including the quarterly and annual Board grants, of $0.7 million and $0.5 million for the years ended December 31, 2020 and 2019, respectively. 

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.